Glaxo settles more Avandia lawsuits in U.S - for a modest sum

 However, last month's relative modest settlement deal and the latest settlement in Philadelphia suggests the amount paid out by the British-based drugmaker is likely to be a lot lower.



http://www.reuters.com/article/idUSTRE6501TC20100601?type=domesticNews&feedType=RSS&feedName=domesticNews



GlaxoSmithKline Plc has settled thousands more lawsuits brought by patients alleging its Avandia diabetes drug caused heart attacks, in a move that may defuse potentially massive claims over the medicine.



U.S.
Health



A company spokeswoman said on Tuesday that consolidated cases which had been due to come to court in Philadelphia this month had been settled. She declined to give further details and said the terms remained confidential.



The first product liability case involving Avandia will now go to court in the United States in October, she added.



The move follows the separate settlement of some 700 cases last month for about $60 million.